Orna Therapeutics

Orna Therapeutics develops innovative methods and drugs in the field of RNA therapeutics. The firm plans to use its products to help treat various kinds of diseases.

NewsHeat chart

Week
Month
Year

Media news
Corp news

Click to unlock the chart

The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice

Company Valuation

Valuation
Share Price
Cumulative Funding

The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.

Funding Round

Funding Amount

Post-Money Valuation

Share Price

Series B16 Aug, 2022

***

Series A24 Feb, 2021

***

Seed1 Jan, 2020

***

*** - To view the data, please log into your account or create a new one.

News related to Orna Therapeutics3

Sort by

Orna Therapeutics

Apr 11, 2024 •Show on chart

Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief ...

PRNewswire/ -- Orna Therapeutics, a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA therapeutics...

https://www.prnewswire.com/news-releases/orna-therapeutics-appoints-frank-neumann-md-phd-as-chief-medical-officer-302113457.html

Orna Therapeutics

Jan 5, 2023 •Show on chart